Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty Sells 6,733 Shares

Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty sold 6,733 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. The trade was a 4.27 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Surgery Partners Price Performance

Shares of NASDAQ SGRY opened at $23.60 on Friday. The stock has a market capitalization of $3.01 billion, a price-to-earnings ratio of -49.17, a PEG ratio of 19.21 and a beta of 2.73. The business has a 50-day moving average of $23.58 and a 200-day moving average of $26.04. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to analysts’ expectations of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. As a group, sell-side analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Surgery Partners

Several hedge funds have recently modified their holdings of SGRY. KBC Group NV grew its holdings in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the period. State of Wyoming grew its holdings in Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company’s stock worth $85,000 after purchasing an additional 1,943 shares during the period. Point72 Asia Singapore Pte. Ltd. grew its holdings in Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company’s stock worth $91,000 after purchasing an additional 465 shares during the period. MeadowBrook Investment Advisors LLC grew its holdings in Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock worth $218,000 after purchasing an additional 1,460 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in Surgery Partners by 279.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company’s stock worth $228,000 after purchasing an additional 7,925 shares during the period.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Royal Bank of Canada dropped their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. Macquarie lowered their target price on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a report on Tuesday, March 11th. Bank of America assumed coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. Finally, JPMorgan Chase & Co. lowered their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $36.63.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.